Three Decades of Innovation in Dialysis Technology

The history of modern dialysis technology is closely linked to continuous innovation in extracorporeal therapies and renal care solutions.

One of the companies that played a major role in the development of dialysis systems was Gambro, founded following the invention of the first artificial kidney by Professor Nils Alwall.

From the Artificial Kidney to Global Dialysis Innovation

The origins of Gambro date back to the collaboration between Professor Nils Alwall and Swedish industrialist Holger Crafoord.

After learning about the life-saving potential of the artificial kidney, Crafoord supported the industrial development and commercialization of dialysis technology.

Development activities started in Lund, Sweden, and the company later adopted the name Gambro, derived from the Swedish expression for “Old Bridge Street Medical Supplies Company.”

Mass production of single-use artificial kidneys and dialysis machines began in 1967.

Expansion of Dialysis Technologies Worldwide

Over the years, Gambro expanded globally and broadened its portfolio through acquisitions and strategic investments.

The company strengthened its position in:

• Renal dialysis systems
• Extracorporeal blood therapies
• Medical disposables
• Critical care technologies

The increasing demand for dialysis treatments has continued to drive innovation in the medical sector.

The Growing Importance of Extracorporeal Therapies

Kidney dialysis was the world’s first extracorporeal therapy, meaning a treatment performed outside the body to support failing organs.

Today, extracorporeal technologies continue to evolve beyond traditional renal dialysis, with applications including:

• Liver dialysis
• Blood purification
• Fluid management
• Toxin removal therapies

These technologies are becoming increasingly important in both chronic and acute patient care.

Global Growth of Dialysis Treatments

The number of dialysis patients worldwide continues to increase steadily due to:

• Aging populations
• Rising diabetes rates
• Hypertension
• Lifestyle-related diseases

Growth is particularly significant in developing economies such as China and India, where access to advanced medical care continues to expand.

This growing demand is accelerating investment in dialysis innovation and extracorporeal medical technologies.

Innovation Remains Essential

As the dialysis industry becomes more technologically advanced and globally integrated, innovation remains essential for improving patient care and treatment efficiency.

The development of new extracorporeal therapies, advanced monitoring systems, and medical sensing technologies continues to shape the future of renal care and critical care medicine worldwide.

Gambro: Three decades of excellence